Employees Retirement System Of Texas Glaukos Corp Transaction History

Employees Retirement System Of Texas

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$38.13 - $68.37 $1.11 Million - $1.98 Million	-29,000 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$27.62 - $44.51 $138,100 - $222,550	-5,000 Reduced 14.71%	29,000 $1.18 Million
Q4 2017 Feb 09, 2018	SELL	$24.5 - $36.01 $1.1 Million - $1.62 Million	-45,000 Reduced 56.96%	34,000 $872,000
Q2 2017 Aug 14, 2017	BUY	N/A	79,000	79,000 $3.28 Million

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.